| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9570 |
| Human Intestinal Absorption | HIA+ | 1.0000 |
| Caco-2 Permeability | Caco2+ | 0.8783 |
| P-glycoprotein Substrate | Non-substrate | 0.6236 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.6589 |
| Non-inhibitor | 0.8726 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8337 |
| Distribution |
| Subcellular localization | Mitochondria | 0.7644 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7246 |
| CYP450 2D6 Substrate | Non-substrate | 0.8947 |
| CYP450 3A4 Substrate | Non-substrate | 0.6665 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.9488 |
| CYP450 2C9 Inhibitor | Inhibitor | 0.6598 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.7153 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.6802 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8840 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7297 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9078 |
| Non-inhibitor | 0.8898 |
| AMES Toxicity | AMES toxic | 0.8505 |
| Carcinogens | Non-carcinogens | 0.9011 |
| Fish Toxicity | High FHMT | 0.7609 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9908 |
| Honey Bee Toxicity | High HBT | 0.7099 |
| Biodegradation | Not ready biodegradable | 0.6784 |
| Acute Oral Toxicity | III | 0.7574 |
| Carcinogenicity (Three-class) | Non-required | 0.5693 |